Literature DB >> 16702401

ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.

Virginie Vives1, Jian Su, Shan Zhong, Indrika Ratnayaka, Elizabeth Slee, Robert Goldin, Xin Lu.   

Abstract

ASPP2 stimulates the apoptotic function of the p53 family in vivo. We show here that ASPP2-/- pups died before weaning. This postnatal lethality was significantly enhanced in p53+/- background and both deletions are synthetic lethal. ASPP2+/- mice developed spontaneous tumors. The tumor onset was accelerated by gamma-irradiation or in p53+/- background. Tumors derived from ASPP2+/- mice retained wild-type ASPP2 allele even though some of them lost p53. These provide the first genetic evidence that ASPP2 is a haploinsufficient tumor suppressor that shares overlapping function(s) with p53 in mouse development and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702401      PMCID: PMC1472901          DOI: 10.1101/gad.374006

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  20 in total

1.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains.

Authors:  X Espanel; M Sudol
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

3.  APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.

Authors:  H Nakagawa; K Koyama; Y Murata; M Morito; T Akiyama; Y Nakamura
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

Review 4.  The ASPP family: deciding between life and death after DNA damage.

Authors:  Elizabeth A Slee; Xin Lu
Journal:  Toxicol Lett       Date:  2003-04-04       Impact factor: 4.372

5.  A role for thrombin receptor signaling in endothelial cells during embryonic development.

Authors:  C T Griffin; Y Srinivasan; Y W Zheng; W Huang; S R Coughlin
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

6.  Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.

Authors:  Izidore S Lossos; Yasodha Natkunam; Ronald Levy; Charles D Lopez
Journal:  Leuk Lymphoma       Date:  2002-12

7.  Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.

Authors:  Ze-Jun Liu; Xin Lu; Yun Zhang; Shan Zhong; Shou-Zhi Gu; Xiao-Bing Zhang; Xin Yang; Hai-Ming Xin
Journal:  FEBS Lett       Date:  2005-03-14       Impact factor: 4.124

8.  ASPP1 and ASPP2: common activators of p53 family members.

Authors:  Daniele Bergamaschi; Yardena Samuels; Boquan Jin; Sai Duraisingham; Tim Crook; Xin Lu
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  ASPP2 inhibits APP-BP1-mediated NEDD8 conjugation to cullin-1 and decreases APP-BP1-induced cell proliferation and neuronal apoptosis.

Authors:  Yuzhi Chen; Wenyun Liu; Louie Naumovski; Rachael L Neve
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

10.  iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.

Authors:  Daniele Bergamaschi; Yardena Samuels; Nigel J O'Neil; Giuseppe Trigiante; Tim Crook; Jung-Kuang Hsieh; Daniel J O'Connor; Shan Zhong; Isabelle Campargue; Matthew L Tomlinson; Patricia E Kuwabara; Xin Lu
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

View more
  50 in total

1.  Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90.

Authors:  Chao Dai; Yi Tang; Sung Yun Jung; Jun Qin; Stuart A Aaronson; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Authors:  Arnaud M Vigneron; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

3.  PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.

Authors:  Chen-Ying Liu; Xianbo Lv; Tingting Li; Yanping Xu; Xin Zhou; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

4.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

5.  Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.

Authors:  Arnaud M Vigneron; Robert L Ludwig; Karen H Vousden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

Review 6.  Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding.

Authors:  Min Lu; Mary R Muers; Xin Lu
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-25       Impact factor: 94.444

7.  Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.

Authors:  David Xu; Donghui Zhou; Khuchtumur Bum-Erdene; Barbara J Bailey; Kamakshi Sishtla; Sheng Liu; Jun Wan; Uma K Aryal; Jonathan A Lee; Clark D Wells; Melissa L Fishel; Timothy W Corson; Karen E Pollok; Samy O Meroueh
Journal:  ACS Chem Biol       Date:  2020-05-21       Impact factor: 5.100

Review 8.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

9.  Autophagic activity dictates the cellular response to oncogenic RAS.

Authors:  Yihua Wang; Xiao Dan Wang; Eleonora Lapi; Alexandra Sullivan; Wei Jia; You-Wen He; Indrika Ratnayaka; Shan Zhong; Robert D Goldin; Christoph G Goemans; Aviva M Tolkovsky; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

10.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.